IGF1 and sarcopenia: These data suggest a connection between mitochondrial dysfunction due to reduced insulin-like growth factor 1 (IGF-I) levels and sarcopenia, and they illustrate several potential metabolic pathways that could play a role in the etiology of the disease (Marques et al. 2023).